Every story in this section, newest first — page 74 of 373.
Viomi Technology (NASDAQ:VIOT) reported unaudited first-half 2026 net revenues of RMB740 million, down 49.9% year over year, as the company faced lower demand following the phase-out of national subsidies and a high prior-year comparison base.
Titan Machinery (NASDAQ:TITN) reported fiscal 2027 second-quarter revenue of $496.4 million, down from $546.4 million a year earlier, while gross margin increased to 18.6% as equipment margins and product mix improved.
Malibu Boats (NASDAQ:MBUU) reported fourth-quarter fiscal 2026 net sales of $295.5 million, up 42.7% year over year, as unit volume increased 19.2% to 1,456 units and adjusted EPS reached $0.92.
Best Buy (NYSE:BBY) reported second-quarter fiscal 2027 revenue of $9.8 billion, up 3.6% year over year, as adjusted earnings per share reached $1.47 and exceeded analyst estimates.
Burlington Stores (NYSE:BURL) reported second quarter 2026 total sales of $2.998 billion, up 11% year over year, while comparable store sales increased 2%.
Build-A-Bear Workshop (NYSE:BBW) reported second quarter fiscal 2026 revenue of $115.3 million, compared with $124.2 million in the same period last year, while pre-tax income reached $11.6 million.
Dollar General (NYSE:DG) reported second quarter fiscal 2026 net sales of $11.3 billion, up 5.2% year over year, while same-store sales increased 3.5%.
Baozun (NASDAQ:BZUN) reported second quarter 2026 net revenues of RMB2,743 million, up 7.5% year over year, supported by growth in services revenue and Brand Management operations.
C3is (NASDAQ:CISS) reported second quarter 2026 voyage revenues of $24 million, up from $10.7 million in the prior-year period, as daily time charter equivalent rates increased to $40,260.
Dollar Tree (NASDAQ:DLTR) reported second quarter fiscal 2026 results with total sales growth of 7% and comparable store net sales growth of 3.7%, supported by higher average customer spending.
Hormel Foods (NYSE:HRL) reported third quarter fiscal 2026 net sales of $2.96 billion, compared with $3.03 billion in the prior-year period, while organic net sales declined 2%.
Bilibili (NASDAQ:BILI) reported second quarter 2026 total net revenues of RMB7.94 billion, up 8% year over year, as advertising revenue increased 28% to RMB3.13 billion.
Lotus Technology (NASDAQ:LOT) reported first half 2026 revenue of $268 million, up 23% year over year, as vehicle deliveries increased 39% to 3,904 units following the launch of the PHEV model Eletre X.
Canadian Solar (NASDAQ:CSIQ) reported second quarter 2026 net revenue of $1.2 billion, up 12% from the previous quarter but down 29% year over year, while battery energy storage shipments increased to 3.7 GWh.
Brent crude futures fell $1.36, or 1.55%, to $86.48 a barrel, while West Texas Intermediate (WTI) crude futures declined $1.40, or 1.7%, to $80.83 as markets reacted to expectations of reduced supply disruptions.
Standard Nuclear (NYSE:STDN) reported second quarter 2026 revenue of $4.7 million, up from $0.6 million in the prior-year period, while total contract backlog later increased to $576.9 million following new customer agreements.
Marvell Technology (NASDAQ:MRVL) reported record fiscal 2027 second-quarter net revenue of $2.739 billion, up 37% year over year and $39 million above the midpoint of its previous guidance.
Mesoblast (NASDAQ:MESO) reported FY2026 total revenue of $120.3 million, up from $17.2 million a year earlier, as the company recorded its first full U.S. commercial year of Ryoncil sales.
Materialise NV (NASDAQ:MTLS) reported second quarter 2026 revenue of EUR70.1 million, up 8.1% year over year, while adjusted EBITDA increased to EUR9.6 million from EUR8.3 million.
CMB.TECH (NYSE:CMBT) reported unaudited second quarter 2026 revenue of USD703.9 million, compared with USD387.8 million in the same period last year, while profit for the period reached USD364.4 million.
AbbVie (NYSE:ABBV) submitted a regulatory application to the European Medicines Agency for subcutaneous SKYRIZI (risankizumab) induction treatment in adults with moderately to severely active Crohn’s disease.
Amgen (NASDAQ:AMGN) and AstraZeneca (NYSE:AZN) reported positive Phase 3 results from the CROSSING trial of TEZSPIRE (tezepelumab-ekko), with the study meeting both primary endpoints in 368 patients with symptomatic eosinophilic esophagitis.
Gaotu Techedu (NYSE:GOTU) reported second quarter 2026 net revenues of RMB1,670.1 million, up 20.2% year over year, as gross billings reached RMB2,689.1 million and gross margin improved to 66.5%.
NVIDIA (NASDAQ:NVDA) reported second quarter fiscal 2027 revenue of $96.2 billion, up 106% year over year, as Data Center revenue reached $89 billion and drove the company’s latest quarterly results.
